Analyst Research

Report Title Price
Provider: Wright Reports
$75.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Tecan Group AG Adjusts FY 2013 Revenue Guidance


Wednesday, 9 Oct 2013 01:21am EDT 

Tecan Group AG announced that based on stable sales for the Group in the first half of 2013 and a lower than anticipated order entry in the Life Science Business to date, the Company now expects moderate growth in local currency terms for fiscal 2013. Previously, Tecan was targeting sales growth to be in the mid-single-digit percentage range for fiscal 2013. The Company reported revenue of CHF391.11 million in fiscal 2012. According to I/B/E/S Estimates, analysts on an average are expecting the Company to report revenue of CHF407.61 million in fiscal 2013. 

Company Quote

103.4
0.8 +0.78%
31 Jul 2014